TF Capital (Shanghai)

TF Capital is a venture capital firm in China that focuses on the life sciences industry and primarily investing in early stage companies. Founded 2013 in Pudong, Shandong, China, it invests in series C, series B and series A rounds. Its portfolio companies include Alpha Biopharma, Eccogene, EOC Pharma Group, and GenFleet Therapeutics. As of April 2020, TF Capital has made 18 investments. Their most recent investment was on December 2, 2019, when EOC Pharma Group raised CN¥500M. EOC Pharma is an integrated biopharmaceutical company. TF Capital has had one exit, which was ZAI Lab. Zai Lab is a biopharmaceutical company based in Shanghai focused on bringing medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.